Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2015 Aug 25;10(8):e0136826. doi: 10.1371/journal.pone.0136826

Correction: Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel

Qian Li, Mei Liu, Fei Ma, Yang Luo, Ruigang Cai, Liming Wang, Ningzhi Xu, Binghe Xu
PMCID: PMC4549142  PMID: 26305791

There is an error in reference 29. The correct reference is: Mo W, Zhang J, Li X, Meng D, Gao Y, Yang S, et al. (2013) Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling through Critical Pathways to Regulate Cell Viability in Prostate Cancer. PLoS ONE 8(2): e56592.

Reference

  • 1. Li Q, Liu M, Ma F, Luo Y, Cai R, Wang L, et al. (2014) Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel. PLoS ONE 9(8): e104870 doi:10.1371/journal.pone.0104870 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES